PATENTS, TRIPS, FLEXIBILITIES & ACCESS TO MEDICINES

Slides:



Advertisements
Similar presentations
Intellectual property rights and procurement = international developments & national experiences = Bi-regional Workshop on procurement and supply management.
Advertisements

DEVELOPING COUNTRIES AND IP: ACCESS TO HEALTH CARE EDUCATION MATERIALS Karen A. LeCuyer, Ph.D. University of Connecticut School of Law 30 May 2007.
1 WTO and medicines: from Doha to Cancún Germán Velásquez Essential Drugs and Medicines Policy World Health Organization Geneva, October 2003.
2 nd WIPO Inter-Regional Meeting on South- South Cooperation on Patents, Trademarks, Geographical Indications, Industrial Designs and Enforcement Cairo.
RECOMMENDATIONS BY INTELLECTUAL PROPERTY LAWYERS ON LEGAL REFORM MOSES NKOMO LL.B, MIP.
Some aspects of the Doha work program Baku, Azerbaijan February 2015.
Possible Impact of Market Exclusivity Extension on Pharmaceuticals in Thailand Chutima Akaleephan International Health Policy Program, Thailand 27 August.
Health Professional Students AIDS Advocacy Network Treat the People: Access to Essential AIDS Medications A Primer for Health Professional Students.
Challenges and Opportunities to Utilize TRIPS Flexibilities in Current Ukrainian Legislation: Potential Impact of IP Provisions in the Proposed EU FTA.
Intellectual Property, Free Trade Agreements and sustainable Development Hanan Sboul Secretary General/ The Jordanian Association of Pharmaceutical Manufacturers.
Intellectual Property Rights, Services and Trade Facilitation CARSTEN FINK African/LDCs Ambassadors Seminar on Post-Hong Kong Assessment of the Doha Round,
1 Licensing Agreements and the Protection of Intellectual Property Chapter 17 © 2005 Thomson/West Legal Studies In Business.
Presentation to Civil Society meeting Lusaka 1 October 2013.
Presentation to Civil Society meeting Maseru 12 August 2014.
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
1 Intellectual Property Rights in Medicines Procurement Patrick Osewe Senior HIV/AIDS Specialist World Bank.
A very short introduction to patents & access to medicines.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA AN OVERVIEW OF PATENT PROTECTION IN ZAMBIA.
TRIPS flexibilities and examples which resulted in reduced medicine prices: Model legislation and compulsory licensing in Brazil Juliana V. Borges Vallini.
Public health, innovation and intellectual property 1 |1 | Dr Germán Velásquez Director WHO Secretariat Public Health, Innovation and Intellectual Property.
Procurement of patented and other essential medicines: challenges and opportunities Wilbert Bannenberg, MD MPH Zambia TRIPS workshop.
TRIPS, Doha and Access to Medicines: Recent Lessons CARSTEN FINK Globalization, Intellectual Property Rights and Social Equity: Challenges and Opportunities.
PATENTS AND HEALTH. A CASE STUDY OF THE UGANDAN CONTEXT. (PHA3 JULY 7 TH 2012 –CAPE TOWN, SOUTH AFRICA) MS. MARIAM AKIROR LLB (HONS) / DIP. SW / CPC. PROG.
Action against AIDS, Germany: Dr. Christiane Fischer MD PHD (presenter )(BUKO Pharma-Kampagne), Astrid Berner Rodoreda (Bread for the World) Igor Oliynyk.
Patents, TRIPS, Flexibilities & Access to Medicines –Legal Perspective Lesotho Civil Society Consultation Meeting 12 August 2014.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
 .
Pricing and the Pharmaceutical Industry What’s Realistic? What’s Smart? What’s Right?
LESOTHO VALIDATION WORKSHOP 25 NOVEMBER 2014 CAILIN MORRISON RECAP – THE INTERNATIONAL CONTEXT: THE WTO, PATENTS, TRIPS FLEXIBILITIES & ACCESS TO MEDICINES.
1 CUTS International Capacity Building Training Programme on Advance IPR, WTO-Related Issues and Patent Writing April 28-May 02, 2008, Jaipur Session 10.
Zimbabwe CSOs TRIPS and Access to medicines Aulline Mabika-Chapisa.
What are the TRIPS flexibilities? How can their incorporation in patent legislation promote access to essential medicines? 25 November 2014, Maseru, Lesotho.
What are the TRIPS flexibilities? How will their incorporation in patent legislation promote access to essential medicines? IP and Access to Medicines:
Ten Years of the Doha Declaration: The State of Implementation Geneva 14 November
Ideas in Development The Potential Impact of WTO Accession, FTAs and Partnership & Cooperation Agreements (PCAs) on Access to Medicines.
The Doha Declaration and the Protocol amending the TRIPS Agreement Islamabad, 28 November 2007 Octavio Espinosa WIPO.
The cases of Guatemala, El Salvador, Honduras, Nicaragua, Dominican Republic and Costa Rica (in process)
UNCTAD/CD-TFT 1 Exclusive Rights and Public Access – Flexibilities in International Agreements and Development Objectives The Public Health Example 21.
© 2008 International Intellectual Property June 24, 2009 Class 8 Patents: Multilateral Agreements (WTO TRIPS); Global Problem of Patent Protection for.
TRIPS+ provisions in FTAs and the implications for access to medicines Sanya Smith Third World Network 27 August 2005.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
A: Copy –Rights – Artistic, Literary work, Computer software Etc. B: Related Rights – Performers, Phonogram Producers, Broadcasters etc. C: Industrial.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN LESOTHO REPORT OF DAY 1 Botha Tiheli, Masello.
Presentation to Civil Society meeting Harare 21 January 2014.
Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies By Yvonne Nkrumah Legal Counsel, Ghana Food and Drugs Board.
WTO and the TRIPS Agreement Wolf R. MEIER-EWERT WTO Secretariat A Business-oriented overview of Intellectual Property for Law Students WIPO, Geneva 20.
A presentation by Moses Nkomo Intellectual Property Attorney and Consultant National Workshop on TRIPS and access to medicines in Zimbabwe Holiday Inn,
Access to Medicines Making Innovation work for the poor Corinna Heineke Diversity in Innovation European Patent Conference, Brussels, 15/16 May 2007.
Implementation of TRIPS Flexibilities In National IP Legislation For Strengthening Access To Medicines In Swaziland Workshop with MOH and stakeholders,
South Africa’s Acceptance of the Protocol Amending the TRIPS Agreement Xolelwa Mlumbi- Peter DDG: ITED 24 November 2015.
The Intellectual Property Provisions of Recent US FTAs CARSTEN FINK Video Conference for Andean Countries on Intellectual Property Rights, May 4, 2005.
Durban, South Africa January 29 to 31, 2013 Topic 13: The Effective Administrative Process for the Grant of Compulsory Licenses Regional Seminar for Certain.
Introduction: Intellectual Property Rights and its impact on access to medicines Anand Grover United Nations Special Rapporteur on Health East Africa Consultation,
TRIPS-Plus Pressures: Trade Agreements, and New Trade Policy Prof. Brook K. Baker OSI Kiev – IPRs & A2M, Sept. 16, 2009.
AIDS DRUGS, NATIONAL EMERGENCY & CIPRO Srividhya Ragavan Nat. Academy For Legal Studies & Research.
Overview: The South African IP Policy Review 13 September 2012 MacDonald Netshitenzhe: Chief Director- Policy and Legislation.
Access v. Patents: We Still Can’t Get Along Srividhya Ragavan University of Oklahoma Law Center.
NAFTA, CAFTA and Access to Medicines and Food Security in Latin America International Aids Conference Session “Globalization and FTAs: their impact, access.
Intellectual Property, Free Trade Agreements and sustainable Development Hanan Sboul Secretary General/ The Jordanian Association of Pharmaceutical Manufacturers.
Intellectual Property and Access to Affordable Medicines: TRIPS Plus
WTO and medicines: from Doha to Cancún
Intellectual Property Protection and Access to Medicines
Access to Treatment: People Before Trade
FTAA and Access to Medicines
WIPO NATIONAL SEMINAR ON INTELLECTUAL PROPERTY RIGHTS AND THE PROTECTION OF PHARMACEUTICAL PRODUCTS Damascus, April 25 and 26, 2005 Current issues on Intellectual.
Béchir N’Daw, UNAIDS Secretariat
Implementation of TRIPS Flexibilities In National IP Legislation For Strengthening Access To Medicines In Swaziland Workshop with MOH and stakeholders,
Acceptance of the Protocol Amending the TRIPS Agreement
Treat the world: Working united across diseases for quality and affordable treatment for all – AIDS 2018 TRIPS Flexibilities 0.2 Across Diseases Ellen.
13-14 August Maseru Lesotho
Presentation transcript:

PATENTS, TRIPS, FLEXIBILITIES & ACCESS TO MEDICINES LESOTHO August 2014 Maseru, Lesotho

OUTLINE OF PRESENTATION - TRIPS Agreement - Industrial Property Order 1989 - Flexibilities - Pre-grant measures - Post-grant measures - The Way Forward / Recommendations

TRIPS AGREEMENT - Signed on 15 April 1994 - Into force on 1 January 1995 - Countries to be compliant by - Developed Countries 1996 - Developing Countries 2000 - Least Developing Countries 2006 date later extended to 2016 further extended to 2021

INDUSTRIAL PROPERTY ORDER, 1989 The Industrial Property Order, 1989, governs patents in Lesotho.

ARIPO ARIPO (automatic applications submitted) Is need to change Letter to ARIPO, no more patents for medicines / pharmaceuticals

FLEXIBILITIES Doha Declaration Reaffirmed - that TRIPS does not and should not prevent Member Countries from taking measures to protect public health and promote access to medicines for all; - the rights of countries to issue compulsory licences at their discretion and not only in cases of emergencies. LDCs Extension of transitional periods (2016, now 2021)

PRE-GRANT MEASURES Patentability standards (S.5 of IP order) Pre-grant patent opposition (public domain, administrative system) Specific exclusions, including the early working of patents, Bolar provisions Section 4 of IP Order lists the exclusions

POST-GRANT MEASURES - Parallel importation of medicines / international exhaustion (pooled procurement) - Government use (e.g. Zimbabwe HIV / AIDS) - Compulsory Licensing (including adequate compensation, and to redress anti- competitive practices e.g. South Africa HIV /AIDS, effectiveness of threat, US biggest user of compulsory licences

POST-GRANT MEASURES CONTINUED - Post-grant opposition (is available but could be made more accessible by administrative system) - Section 16 of IP Order

THE WAY FORWARD / RECOMMENDATIONS - Incorporation of TRIPS Flexibilities - Avoidance of TRIPS Plus (such as data exclusivity provisions in Free Trade Agreements, Patent term extensions, Also in Free Trade Agreements avoid limiting conditions for Compulsory Licensing, patent linkage, patent policing)

THE WAY FORWARD / RECOMMENDATIONS CONTINUED - This presentation was about public health priorities for the law reform process. - There other law reform initiatives affecting access, these are separate.

THANK YOU